Cocrystal Pharma Boosts Executive and Director Compensation

The latest announcement is out from Cocrystal Pharma ( (COCP) ).

Cocrystal Pharma, Inc. has rewarded its top executives and non-employee directors with significant financial incentives following the Board of Directors’ ratification of the Compensation Committee’s decisions. Both Co-CEOs received a salary increase to $416,000, a $200,000 bonus, and 40,000 restricted stock units (RSUs). Additionally, non-employee directors were granted cash stipends ranging from $36,300 to $100,000 and RSUs between 8,067 and 28,109, with half of the RSUs vesting immediately and the rest over two years. These moves underscore the company’s commitment to retaining and motivating its leadership team.

See more insights into COCP stock on TipRanks’ Stock Analysis page.